NewAmsterdam Pharma (NAMS) Property, Plant & Equipment (Net) (2021 - 2026)

NewAmsterdam Pharma (NAMS) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 NewAmsterdam Pharma 3.68 Bn 3.68 Bn - 379,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 379,000.00
Mar 31, 2026 379,000.00
Dec 31, 2025 383,000.00
Dec 31, 2025 383,000.00
Sep 30, 2025 323,000.00
Sep 30, 2025 323,000.00
Jun 30, 2025 312,000.00
Jun 30, 2025 312,000.00
Mar 31, 2025 238,000.00
Mar 31, 2025 238,000.00
Dec 31, 2024 242,000.00
Dec 31, 2024 242,000.00
Sep 30, 2024 231,000.00
Sep 30, 2024 231,000.00
Jun 30, 2024 234,000.00
Jun 30, 2024 234,000.00
Mar 31, 2024 101,000.00
Mar 31, 2024 101,000.00
Dec 31, 2023 46,000.00
Dec 31, 2023 46,000.00